Therefore, it was hypothesized that low expression of HTR2A and HTR2B inhibits the activation of CD8+ T cells, and subsequently promotes breast cancer invasion and leads to poor prognosis of breast cancer patients. The gene discussed is HTR2B; the disease is breast carcinoma.